Evaluation of Charlson comorbidity index as predictor of survival in stage II-III colorectal cancer patients treated with surgery and neoadjuvant/adjuvant chemotherapy: A single Institution observational study

被引：0
|
作者：
Baretti, M. [1 ]
Personeni, N. [1 ]
Giordano, L. [1 ]
Tronconi, M. C. [1 ]
Pressiani, T. [1 ]
Bozzarelli, S. [1 ]
Rimassa, L. [1 ]
Santoro, A. [2 ]
机构：
[1] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
[2] Humanitas Univ, Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw370.104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
556P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy
    Ahn, Daniel H.
    Wu, Christina
    Wei, Lai
    Williams, Terence M.
    Wuthrick, Evan
    Abdel-Misih, Sherif
    Harzman, Alan
    Husain, Syed
    Schmidt, Carl
    Goldberg, Richard M.
    Bekaii-Saab, Tanios
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (06): : 531 - 534
  • [22] The Impact of Age-adjusted Charlson Comorbidity Index on Survival in Patients With Early-stage Uterine Carcinoma - A Single Institution Study
    Robbins, J. R.
    Gayar, O. H.
    Zaki, M. A.
    Mahan, M. G.
    Buekers, T.
    Elshaikh, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S98 - S98
  • [23] Neoadjuvant biweekly chemotherapy with liposomal doxorubicin and docetaxel in patients with stage II-III breast cancer
    Alvarez, I
    Modolell, A.
    Mayordomo, J., I
    Heras, L.
    Villadiego, K.
    Rolfo, C. D.
    Garcia-Bueno, J. M.
    Pica, P.
    Murillo, L.
    Morales, S.
    Valera, P.
    Florian, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [24] The benefit of adjuvant chemotherapy in elderly patients with stage III colorectal cancer is independent of age and comorbidity
    Wildes, Tanya M.
    Kallogjeri, Dorina
    Powers, Brian
    Vlahiotis, Anna
    Mutch, Matthew
    Spitznagel, Edward L., Jr.
    Tan, Benjamin
    Piccirillo, Jay F.
    JOURNAL OF GERIATRIC ONCOLOGY, 2010, 1 (02) : 48 - 56
  • [25] Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
    Babaei, Masoud
    Balavarca, Yesilda
    Jansen, Lina
    Lemmens, Valery
    van Erning, Felice N.
    van Eycken, Liesbet
    Vaes, Evelien
    Sjovall, Annika
    Glimelius, Bengt
    Ulrich, Cornelia M.
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (07) : 1480 - 1489
  • [26] Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer
    Jiang, Yuming
    Li, Tuanjie
    Liang, Xiaoling
    Hu, Yanfeng
    Huang, Lei
    Liao, Zhenchen
    Zhao, Liying
    Han, Zhen
    Zhu, Shuguang
    Wang, Menglan
    Xu, Yangwei
    Qi, Xiaolong
    Liu, Hao
    Yang, Yang
    Yu, Jiang
    Liu, Wei
    Cai, Shirong
    Li, Guoxin
    JAMA SURGERY, 2017, 152 (07) : e171087
  • [27] Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer:: a multicentre randomised controlled phase III trial
    Nordlinger, B
    Rougier, P
    Arnaud, JP
    Debois, M
    Wils, J
    Ollier, JC
    Grobost, O
    Lasser, P
    Wals, J
    Lacourt, J
    Seitz, JF
    dos Santos, JG
    Bleiberg, H
    Mackiewickz, R
    Conroy, T
    Bouché, O
    Morin, T
    Baila, L
    van Cutsem, E
    Bedenne, L
    LANCET ONCOLOGY, 2005, 6 (07): : 459 - 468
  • [28] Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study
    Kim, Ki-Yeol
    Cha, In-Ho
    Ahn, Joong Bae
    Kim, Nam Kyu
    Rha, Sun Young
    Chung, Hyun Cheol
    Roh, Jae Kyung
    Shin, Sang Joon
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (06) : 613 - 618
  • [29] Evaluation of α-1-acid glycoprotein as a prognostic factor of survival in patients with stage II-III esophageal carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil chemotherapy followed by surgery.
    Sasaki, Yusuke
    Kato, Ken
    Furuta, Koh
    Takahashi, Naoki
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko T.
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Time to initiation of adjuvant chemotherapy and survival in patients with stage II and III rectal cancer not receiving total neoadjuvant therapy
    Huai, Siyuan
    Zhao, Xuanzhu
    Wang, Shuyuan
    Li, Hongzhou
    Yuan, Zhen
    Pang, Wenwen
    Wang, Wanting
    Han, Qiurong
    Yao, Yao
    Chu, Tianhao
    Feng, Zhiqiang
    Liu, Yanfei
    Yan, Suying
    Jin, Leixin
    Zhang, Qinghuai
    Zhang, Xipeng
    Dong, Xuetao
    Xue, Jun
    Zhang, Chunze
    ONCOLOGIE, 2024, 26 (03) : 457 - 465
12345